0 items USD 0.00Search
Your search for "qyresearch china biosimilar monoclonal antibodies industry 2016 market research report" gave back 763003 results.
The global Adalimumab Monoclonal Antibody Biosimilar market size was valued at USD 433.2 million in 2022 and is forecast to a readjusted size of USD...
Catalog:
GIR
June 2023
Price: USD 3,480.00
The global Bevacizumab Monoclonal Antibody Biosimilar market size was valued at USD 1379.8 million in 2022 and is forecast to a readjusted size of...
Catalog:
GIR
June 2023
Price: USD 3,480.00
The global Biosimilar Antibodies market size was valued at USD million in 2023 and is forecast to a readjusted size of USD million by 2030 with a...
Catalog:
GIR
March 2024
Price: USD 3,480.00
The global Biologics and Biosimilars market size was valued at USD 481830 million in 2023 and is forecast to a readjusted size of USD 842330 million...
Catalog:
GIR
January 2024
Price: USD 3,480.00
The global Biosimilar market size was valued at USD million in 2023 and is forecast to a readjusted size of USD million by 2030 with a CAGR of %...
Catalog:
GIR
January 2024
Price: USD 3,480.00
The global Biosimilar Antibodies market size is expected to reach $ million by 2030, rising at a market growth of % CAGR during the forecast period (...
Catalog:
GIR
March 2024
Price: USD 4,480.00
The global Biologics and Biosimilars market size was valued at US$ 458090 million in 2023. With growing demand in downstream market, the Biologics...
Catalog:
LPI
January 2024
Price: USD 3,660.00
Biologics are very specific, highly effective medicines made in living cells, and historically this was often an animal. Biologics include hormones,...
Catalog:
MRRPB5
November 2023
Price: USD 3,350.00
Trastuzumab, sold under the brand name Herceptin among others, is a monoclonal antibody used to treat breast cancer and stomach cancer. The global...
Catalog:
MRRPB5
June 2023
Price: USD 2,900.00
RITUXAN® (rituximab) is a prescription medicine used to treat: Adults with Non-Hodgkin's Lymphoma (NHL): alone or with other chemotherapy...
Catalog:
MRRPB5
June 2023
Price: USD 2,900.00
The global Biosimilar market size was valued at US$ million in 2023. With growing demand in downstream market, the Biosimilar is forecast to a...
Catalog:
LPI
January 2024
Price: USD 3,660.00
The global Biosimilar and Biologics market size was valued at USD million in 2023 and is forecast to a readjusted size of USD million by 2030 with a...
Catalog:
GIR
March 2024
Price: USD 3,480.00
The global Trastuzumab Monoclonal Antibody market size is expected to reach $ 6357.7 million by 2029, rising at a market growth of 4.6% CAGR during...
Catalog:
GIR
June 2023
Price: USD 4,480.00
Infliximab is a monoclonal anti tumor necrosis factor alpha antibody used in the treatment of a wide variety of inflammatory conditions such as...
Catalog:
MRRPB5
June 2023
Price: USD 2,900.00
The global Trastuzumab Monoclonal Antibody market size is projected to grow from US$ 4413.9 million in 2022 to US$ 6202.2 million in 2029; it is...
Catalog:
LPI
June 2023
Price: USD 3,660.00
